Literature DB >> 7378008

Effects of ocular decongestants.

M B Abelson, G K Yamamoto, M R Allansmith.   

Abstract

Eight widely used commercially available ocular decongestants were compared on the basis of vasoconstrictive effectiveness. The ability of these preparations to counteract histamine-induced erythema and to block its recurrence when rechallenged after one hour was evaluated in six human subjects in seven sessions. All vasoconstrictors tested were effective. No preparation was statistically different from 0.02% naphazoline hydrochloride in vasoconstrictive effect. In fact, this intermediate concentration of naphazoline (0.02%) was found to be significantly better that the other nonprescription decongestant preparations tested as a group and not significantly different from a group of higher concentrations of naphazoline.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378008     DOI: 10.1001/archopht.1980.01020030850009

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

Review 1.  Conjunctival allergen challenge: models in the investigation of ocular allergy.

Authors:  Mark B Abelson; Oliver Loeffler
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

Review 2.  Antihistamines in ocular allergy: are they all created equal?

Authors:  Mark B Abelson; James T McLaughlin; Paul J Gomes
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

3.  Evaluation of alpha-adrenomimetic agents for gingival retraction: A randomized crossover clinical trial.

Authors:  Neha Mehra; Ajita Rathi; Roshni Sharma; Mamta Kaushik; Tanushree Sood
Journal:  J Conserv Dent       Date:  2020-08-20

Review 4.  Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management.

Authors:  Stacey Ackerman; Lisa M Smith; Paulo J Gomes
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

Review 5.  Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Ann Yung; Sonia Anchouche; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-15       Impact factor: 6.268

6.  Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials.

Authors:  Stacey L Ackerman; Gail L Torkildsen; Eugene McLaurin; Jason L Vittitow
Journal:  Clin Exp Optom       Date:  2018-12-07       Impact factor: 2.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.